What is Alecensa used to treat?
Alecensa (alectinib) is used to treat advanced non-small cell lung cancer that is caused by a mutation in the anaplastic lymphoma kinase (ALK) gene.
The ALK gene mutation is detected by an FDA approved test.
People with the ALK gene mutation who have non-small cell lung cancer that has spread to other parts of the body have ALK-positive metastatic non-small cell lung cancer (NSCLC).
ALK-positive NSCLC is often found in younger people who have a light or non-smoking history. Approximately 5 percent of people with NSCLC in the United States are ALK-positive.
Alecensa belongs to the class of drugs called multikinase inhibitors. It works by targeting anaplastic lymphoma kinase (ALK) to help slow or stop tumor growth.
Related medical questions
- How effective is Alecensa for ALK-positive NSCLC?
- How long do you take Alecensa for?
- How does Alecensa work?
- Is small cell or non-small cell lung cancer worse?
- What type of cancer is Tecentriq used to treat?
- What type of lung cancer is Vizimpro used to treat?